Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $33.00 at Royal Bank Of Canada
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price target hoisted by equities researchers at Royal Bank Of Canada from $30.00 to $33.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price suggests a potential […]
10 Jul 13:42 · The Markets Daily